Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Feb 1;2(1):ofv018. doi: 10.1093/ofid/ofv018

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.

PMC Copyright notice

Figure 2. — (A) Summary of fasting lipids and Framingham score at baseline and M6: all antiretroviral (ARV), protease inhibitor (PI) regimen, and efavirenz (EFV) regimen before single-tablet regimen (STR) switch. P values for fasting lipid and Framingham parameters compared at baseline vs M6. (B) Summary of creatinine parameters at baseline and M6 for all ARV. Abbreviation: ns, not significant.

Figure 2. — (A) Summary of fasting lipids and Framingham score at baseline and M6: all antiretroviral (ARV), protease inhibitor (PI) regimen, and efavirenz (EFV) regimen before single-tablet regimen (STR) switch. P values for fasting lipid and Framingham parameters compared at baseline vs M6. (B) Summary of creatinine parameters at baseline and M6 for all ARV. Abbreviation: ns, not significant.